Joseph M. Davie
Director/Board Member at Stratatech Corp.
Profile
Dr. Joseph M.
Davie is an Advisor at RiverVest Venture Management LLC.
He is on the Board of Directors at Stratatech Corp.
and The Johns Hopkins University.
Dr. Davie was previously employed as a Senior Vice President-Research by Biogen Idec MA, Inc., a President-Research & Development by G.D.
Searle & Co., Inc., and a Professor by University of Washington.
He also served on the board at CV Therapeutics, Inc., Curis, Inc., AmpliPhi Biosciences Corp., American Society for Investigative Pathology, Auxeris Therapeutics, Inc., BG Medicine, Inc., Inflazyme Pharmaceuticals Ltd., Keel Pharmaceuticals, Inc., Metaphore Pharmaceuticals, Inc., NeoGenesis Pharmaceuticals, Inc. and Ocera Therapeutics, Inc. /Old/.
He received his undergraduate degree from Indiana University, a graduate degree from Indiana University, a doctorate degree from the University of Washington and a doctorate degree from Indiana University.
Joseph M. Davie active positions
| Companies | Position | Start |
|---|---|---|
| The Johns Hopkins University | Director/Board Member | - |
Stratatech Corp.
 Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Director/Board Member | - |
Former positions of Joseph M. Davie
| Companies | Position | End |
|---|---|---|
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Director/Board Member | 2013-07-15 |
| CURIS, INC. | Director/Board Member | 2011-09-15 |
| BG MEDICINE, INC. | Director/Board Member | 2009-12-29 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Director/Board Member | 2009-04-16 |
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Director/Board Member | 2007-11-15 |
Training of Joseph M. Davie
| University of Washington | Doctorate Degree |
| Indiana University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| BG MEDICINE, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
| Keel Pharmaceuticals, Inc. | |
Stratatech Corp.
Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Commercial Services |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Auxeris Therapeutics, Inc.
 Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO | Health Technology |
Metaphore Pharmaceuticals, Inc.
 Metaphore Pharmaceuticals, Inc. BiotechnologyHealth Technology Metaphore Pharmaceuticals, Inc. is a pharmaceutical company which discovers, develops and markets drugs that prevent and treat pain, autoimmune disorders and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human enzymes. The company's compounds mimic the function of superoxide dismutase (SOD), a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a variety of diseases associated with pain and inflammation. The company is headquartered in St. Louis, MO. | Health Technology |
Ocera Therapeutics, Inc. /Old/
Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Health Technology |
American Society for Investigative Pathology
 American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
- Stock Market
- Insiders
- Joseph M. Davie
